Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Home
Latest Articles
Latest Articles
ESMO 2019: Positive Results of Olaparib + Bevacizumab in Newly-Diagnosed Advanced Ovarian Cancer
Peter Hofland, Ph.D
-
September 28, 2019
Research Shows Molecular Engine That Drives Pancreatic Cancer and Ways to Turn It Off
Researchers Find New Way to Treat Aggressive form of Brain Tumor
US FDA to Review Isatuximab as a Potential Treatment for R/R Multiple Myeloma
While Oncologists? Pay Attention to Patients? Weight Management and Diet they Infrequently Refer to Support Lifestyle Changes
Daiichi Sankyo Accelerates Biologics License Application for Trastuzumab Deruxtecan
Peter Hofland, Ph.D
-
March 29, 2019
Oxybutynin Improved Quality of Life for Breast Cancer Survivors
Peter Hofland, Ph.D
-
December 8, 2018
Investigational Compound from Chinese Tree Bark Shows Potential as Treatment for...
Peter Hofland, Ph.D
-
November 7, 2018
Oral Sores and Cancer Treatment
Alisa Cooper Wechsler
-
May 11, 2018
First-line Treatment with Pembrolizumab
Peter Hofland, Ph.D
-
April 16, 2018
First Patients Enrolled in Landmark Lung Cancer Tri-Therapy Clinical Trial
Peter Hofland, Ph.D
-
January 19, 2018
Charitable Efforts Know No Boundaries When Helping the Underserved? Stakeholders Strive...
Eric T. Rosenthal
-
September 25, 2017
Anti-Leukemic Activity and Safety Data for Gilteritinib in Relapsed
Peter Hofland, Ph.D
-
June 23, 2017
Eric Rosenthal Reports: Placing Cancer Fear in its Proper Perspective
Eric T. Rosenthal
-
June 21, 2017
Palbociclib may have Wider Applicability in Targeting Cancer
Peter Hofland, Ph.D
-
June 15, 2017
1
2
3
Page 1 of 3
LATEST
First Targeted Therapy Approved for Rare Mutation of Gastrointestinal Stromal Tumors
Peter Hofland, Ph.D
-
January 10, 2020
The Nuts & Bolts of High Intensity Focal Ultrasound
John Russell Valvo, MD
-
January 10, 2020
Scientists Discover Previously Unknown Role of Immune Signaling Protein in Pancreatic Cancer
Peter Hofland, Ph.D
-
January 8, 2020
